Eka Yudhanto. FK Undip / RSND Semarang

Size: px
Start display at page:

Download "Eka Yudhanto. FK Undip / RSND Semarang"

Transcription

1 Eka Yudhanto FK Undip / RSND Semarang

2 Scoring system : To treat thyroid malignancies appropriately, clinicians must have methods to accurately assess the behavior and outcomes from treatment of differentiated thyroid carcinoma

3 Scoring system :

4 Recommendation (ATA guidelines task force 2015): What is the appropriate operation for differentiated thyroid cancer? The goal of thyroid surgery : provision of a diagnosis after a nondiagnostic or indeterminate biopsy removal of the thyroid cancer staging Preparation for radioactive ablation

5 Because of an increased risk for malignancy, total thyroidectomy is indicated in patients with large tumors ( 4 cm) when marked atypia is seen on biopsy, when the biopsy reading is suspicious for papillary carcinoma, in patients with a family history of thyroid carcinoma, and in patients with a history of radiation exposure Recommendation A Patients with bilateral nodular disease or those who prefer to undergo bilateral thyroidectomy to avoid the possibility of requiring a future surgery on the contralateral lobe should also undergo total thyroidectomy Recommendation A

6 For patients with thyroid cancer > 1 cm and < 4 cm without extrathyroidal extension, and without clinical evidence of any lymph node metastases (cn0), the initial surgical procedure can be either a bilateral procedure (neartotal or total thyroidectomy) or a unilateral procedure (lobectomy). Thyroid lobectomy alone may be sufficient initial treatment for low-risk papillary and follicular carcinomas; however, the treatment team may choose total thyroidectomy to enable RAI therapy or to enhance followup based upon disease features and/or patient preferences. (Strong recommendation, Moderate-quality evidence)

7 If surgery is chosen for patients with thyroid cancer < 1 cm without extrathyroidal extension and cn0, the initial surgical procedure should be a thyroid lobectomy unless there are clear indications to remove the contralateral lobe. Thyroid lobectomy alone is sufficient treatment for small, unifocal, intrathyroidal carcinomas in the absence of prior head and neck radiation, familial thyroid carcinoma, or clinically detectable cervical nodal metastases. (Strong recommendation, Moderate-quality evidence)

8 Therapeutic central-compartment (level VI) neck dissection for patients with clinically involved central nodes should accompany total thyroidectomy to provide clearance of disease from the central neck. (Strong recommendation, Moderate-quality evidence) Prophylactic central-compartment neck dissection (ipsilateral or bilateral) should be considered in patients with papillary thyroid carcinoma with clinically uninvolved central neck lymph nodes (cn0) who have advanced primary tumors (T3 or T4) or clinically involved lateral neck nodes (cn1b), or if the information will be used to plan further steps in therapy. (Weak recommendation, Lowquality evidence)

9 Thyroidectomy without prophylactic central neck dissection is appropriate for small (T1 or T2), noninvasive, clinically node-negative PTC (cn0) and for most follicular cancers. (Strong recommendation, Moderatequality evidence) Therapeutic lateral neck compartmental lymph node dissection should be performed for patients with biopsy-proven metastatic lateral cervical lymphadenopathy. (Strong recommendation, Moderate-quality evidence)

10 Completion thyroidectomy should be offered to patients for whom a bilateral thyroidectomy would have been recommended had the diagnosis been available before the initial surgery. Therapeutic central neck lymph node dissection should be included if the lymph nodes are clinically involved. Thyroid lobectomy alone may be sufficient treatment for low-risk papillary and follicular carcinomas. (Strong recommendation, Moderate-quality evidence) RAI ablation in lieu of completion thyroidectomy is not recommended routinely; however, it may be used to ablate the remnant lobe in selected cases. (Weak recommendation, Low-quality evidence)

11 Implications : Patients : Strong recommendation : Most would want course of action; a person should request discussion if an intervention is not offered. Weak recommendation : Many would want course of action, but some may not; the decision may depend on individual circumstances. Clinicians : Strong recommendation : Most patients should receive the recommended course of action. Weak recommendation : Different choices will be appropriate for different patients; the management decision should be consistent with patients preferences and circumstances.

12 Implications : Policy Makers : Strong recommendation : The recommendation can be adopted as policy in most circumstances. Weak recommendation : Policymaking will require careful consideration and stakeholder input....

13 References:

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科 Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科 Papillary microcarcinoma of thyroid Definition latent aberrant thyroid occult thyroid carcinoma latent papillary carcinoma)

More information

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:

More information

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH 9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing

More information

Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery

Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery Update on thyroid cancer surveillance and management of recurrent disease Minimally invasive thyroid surgery July 2006 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor, David

More information

Latest Oncologic Strategies for Well-Differentiated Thyroid Carcinoma

Latest Oncologic Strategies for Well-Differentiated Thyroid Carcinoma Latest Oncologic Strategies for Well-Differentiated Thyroid Carcinoma April 2008 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor of Surgery and Medicine David Geffen School of

More information

Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD

Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence Cord Sturgeon, MD Associate Professor of Surgery Northwestern University Feinberg School of Medicine Director of Endocrine Surgery Chicago,

More information

Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer THYROID Volume 16, Number 2, 2006 American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Taskforce*

More information

Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)

Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules) Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules) Jeffrey S. Freeman, D.O., F.A.C.O.I. Chairman, Division of Endocrinology and Metabolism Philadelphia College

More information

THYROID CANCER. I. Introduction

THYROID CANCER. I. Introduction THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in

More information

Thyroid Cancer Diagnosis and Management. Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010

Thyroid Cancer Diagnosis and Management. Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010 Thyroid Cancer Diagnosis and Management Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010 DISCLOSURE NOTHING TO DISCLOSE in regard to financial conflict

More information

Advances in Differentiated Thyroid Cancer

Advances in Differentiated Thyroid Cancer Advances in Differentiated Thyroid Cancer Steven A. De Jong, M.D., FACS, FACE Professor and Vice Chair Clinical Affairs Department of Surgery Loyola University Medical Center Thyroid Cancer classification

More information

Thyroid and Adrenal Gland

Thyroid and Adrenal Gland Thyroid and Adrenal Gland NAACCR 2011 2012 Webinar Series 12/1/11 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve,

Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve, Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve, Larynx, Trachea, & Esophageal Management Robert C. Wang,

More information

Management of Differentiated Thyroid Carcinoma American Thyroid Association Guidelines and Data from Kaohsiung Chang Gung Memorial Hospital

Management of Differentiated Thyroid Carcinoma American Thyroid Association Guidelines and Data from Kaohsiung Chang Gung Memorial Hospital Review Management of Differentiated Thyroid Carcinoma American Thyroid Association Guidelines and Data from Kaohsiung Chang Gung Memorial Hospital Pei-Wen Wang Abstract Background. Most thyroid cancers

More information

Locoregional recurrence or persistence of papillary carcinoma: radioiodine treatment

Locoregional recurrence or persistence of papillary carcinoma: radioiodine treatment Locoregional recurrence or persistence of papillary carcinoma: radioiodine treatment Michele Klain, Marco Salvatore Department of Functional and Biomorphological Science University of Naples "Federico

More information

Preventable reoperations for persistent and recurrent papillary thyroid carcinoma

Preventable reoperations for persistent and recurrent papillary thyroid carcinoma Preventable reoperations for persistent and recurrent papillary thyroid carcinoma Maria A. Kouvaraki, MD, PhD, Jeffrey E. Lee, MD, Suzanne E. Shapiro, MS, Steven I. Sherman, MD, and Douglas B. Evans, MD,

More information

BRAF in the diagnostic evaluation of thyroid nodules

BRAF in the diagnostic evaluation of thyroid nodules Symposium 13 Molecular markers in thyroid cancer: current role in clinical practice BRAF in the diagnostic evaluation of thyroid nodules Laura Fugazzola University of Milan, Italy Papillary carcinoma BRAF

More information

Followup of Patients with Papillary Thyroid Cancer: In Search of the Optimal Algorithm

Followup of Patients with Papillary Thyroid Cancer: In Search of the Optimal Algorithm Followup of Patients with Papillary Thyroid Cancer: In Search of the Optimal Algorithm Elizabeth A Mittendorf, MD, Xuemei Wang, MS, Nancy D Perrier, MD, Ashleigh M Francis, BSPH, Beth S Edeiken, MD, Suzanne

More information

Hemithyroidectomy increases the risk of disease recurrence in patients with ipsilateral multifocal papillary thyroid carcinoma

Hemithyroidectomy increases the risk of disease recurrence in patients with ipsilateral multifocal papillary thyroid carcinoma 1412 Hemithyroidectomy increases the risk of disease recurrence in patients with ipsilateral multifocal papillary thyroid carcinoma XIAOLONG LI 1*, CUI ZHAO 1*, DANDAN HU 1, YANG YU 1, JIN GAO 2, WENCHUAN

More information

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer THYROID Volume 19, Number 11, 2009 ª Mary Ann Liebert, Inc. DOI: 10.1089=thy.2009.0110 ORIGINAL STUDIES, REVIEWS, AND SCHOLARLY DIALOG THYROID CANCER AND NODULES Revised American Thyroid Association Management

More information

Conflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F.

Conflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates Jeffrey F. Krane, MD PhD Associate Professor of Pathology Harvard Medical School Chief, Head and Neck Pathology Service Associate Director,

More information

AACE/AAES MEDICAL/SURGICAL GUIDELINES FOR CLINICAL PRACTICE: MANAGEMENT OF THYROID CARCINOMA

AACE/AAES MEDICAL/SURGICAL GUIDELINES FOR CLINICAL PRACTICE: MANAGEMENT OF THYROID CARCINOMA AACE/AAES MEDICAL/SURGICAL GUIDELINES FOR CLINICAL PRACTICE: MANAGEMENT OF THYROID CARCINOMA Thyroid Carcinoma Task Force Co-Chairpersons Rhoda H. Cobin, MD, FACE Hossein Gharib, MD, FACP, FACE Committee

More information

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer THYROID Volume 26, Number 1, 2016 ª American Thyroid Association ª Mary Ann Liebert, Inc. DOI: 10.1089/thy.2015.0020 SPECIAL ARTICLE 2015 American Thyroid Association Management Guidelines for Adult Patients

More information

Thyroid Cancer A Multidisciplinary Approach

Thyroid Cancer A Multidisciplinary Approach Thyroid Cancer A Multidisciplinary Approach Shuvendu Sen, MD, MS, FACP Associate Program Director, Internal Medicine Residency Program Director, Medical Education Raritan Bay Medical Center, Rutgers University

More information

Post-PET Restaging Cancer Form National Oncologic PET Registry

Post-PET Restaging Cancer Form National Oncologic PET Registry Post-PET Restaging Cancer Form National Oncologic PET Registry Facility ID #: Registry Case Number: Patient Name: Your patient had a PET scan on: mm/dd/yyyy. The PET scan was done for restaging of (cancer

More information

The epidemic of thyroid cancer and its evolving management: Is less more?

The epidemic of thyroid cancer and its evolving management: Is less more? The epidemic of thyroid cancer and its evolving management: Is less more? Julie Ann Sosa, MD MA FACS Professor of Surgery and Medicine Chief, Section of Endocrine Surgery, and Leader, Endocrine Neoplasia

More information

MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15

MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15 MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,

More information

Should All Papillary Thyroid Microcarcinomas Be Aggressively Treated? An Analysis of 18,445 Cases

Should All Papillary Thyroid Microcarcinomas Be Aggressively Treated? An Analysis of 18,445 Cases PAPERS OF THE 131ST ASA ANNUAL MEETING Should All Papillary Thyroid Microcarcinomas Be Aggressively Treated? An Analysis of 18,445 Cases Xiao-Min Yu, MD, PhD, Yin Wan, MS, Rebecca S. Sippel, MD, FACS,

More information

Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare

Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Maria Chiara Zatelli Sezione di Endocrinologia Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università

More information

Current Treatment of Papillary Thyroid Microcarcinoma

Current Treatment of Papillary Thyroid Microcarcinoma Advances in Surgery 46 (2012) 191 203 ADVANCES IN SURGERY Current Treatment of Papillary Thyroid Microcarcinoma Xiao-Min Yu, MD, PhD a, Ricardo Lloyd, MD, PhD b, Herbert Chen, MD c, * a Department of Surgery,

More information

Influence of Initial Treatment on the Survival and Recurrence in Patients With Differentiated Thyroid Microcarcinoma

Influence of Initial Treatment on the Survival and Recurrence in Patients With Differentiated Thyroid Microcarcinoma ORIGINAL ARTICLE Influence of Initial Treatment on the Survival and Recurrence in Patients With Differentiated Thyroid Microcarcinoma Jasna Mihailovic, MD, PhD,*Þ Ljubomir Stefanovic, MD, PhD,* and Ranka

More information

TNM Staging of Head and Neck Cancer and Neck Dissection Classification

TNM Staging of Head and Neck Cancer and Neck Dissection Classification QUICK REFERENCE GUIDE TO TNM Staging of Head and Neck Cancer and Neck Dissection Classification Fourth Edition 2014 All materials in this ebook are copyrighted by the American Academy of Otolaryngology

More information

WELL DIFFERENTIATED THYROID CANCER

WELL DIFFERENTIATED THYROID CANCER Scandinavian Journal of Surgery 93: 261 271, 2004 WELL DIFFERENTIATED THYROID CANCER N. R. Caron, O. H. Clark Department of Surgery, University of California, San Francisco and UCSF Comprehensive Cancer

More information

Molecular Diagnostics in Thyroid Cancer

Molecular Diagnostics in Thyroid Cancer Disclosure Nothing to disclose Jonathan George, MD, MPH Assistant Professor Head and Neck Oncologic & Endocrine Surgery Molecular Diagnostics in Thyroid Cancer Current Practices & Future Trends UCSF Medical

More information

Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma

Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma Clinical Endocrinology (2014) 81, 282 288 doi: 10.1111/cen.12417 ORIGINAL ARTICLE Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma Yinlong Yang*,, Chengze Chen,

More information

Management of Well Differentiated Thyroid Cancers: Where We Have Been and Where We are Headed

Management of Well Differentiated Thyroid Cancers: Where We Have Been and Where We are Headed Management of Well Differentiated Thyroid Cancers: Where We Have Been and Where We are Headed Medical Grand Rounds December 10,2015 Christine Signore, MD ECNU Learning Objectives Discuss the epidemiology

More information

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing

More information

The incidence of thyroid cancer has increased exponentially over

The incidence of thyroid cancer has increased exponentially over FEATURE THYROID Papillary thyroid cancer: the most common endocrine malignancy JAMES C. LEE FRACS STANLEY B. SIDHU FRACS, PhD Papillary thyroid cancer has an excellent prognosis and over 90% of affected

More information

Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid

Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_markers_in_fine_needle_aspirates_of_the_thyroid

More information

The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.

The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers. Where does Molecular Analysis of FNA Specimens fit into the evaluation of thyroid nodules? The Role of Genetic Testing in the Evaluation of Thyroid Nodules Ultrasound TSH Risk factors Jill E. Langer, MD

More information

Papillary thyroid cancer accounts for approximately 90% Lymph Node Dissection in Papillary Thyroid Carcinoma

Papillary thyroid cancer accounts for approximately 90% Lymph Node Dissection in Papillary Thyroid Carcinoma Lymph Node Dissection in Papillary Thyroid Carcinoma Tracy-Ann S. Moo, MD, and Thomas J. Fahey III, MD The management of papillary thyroid carcinoma continues to evolve. Although the debate over the extent

More information

Releasing Nuclear Medicine Patients to the Public: Dose Calculations and Discharge Instructions

Releasing Nuclear Medicine Patients to the Public: Dose Calculations and Discharge Instructions Educational Objectives Releasing Nuclear Medicine Patients to the Public: Dose Calculations and Discharge Instructions Robert E. Reiman, MD Radiation Safety Division Duke University Medical Center Durham,

More information

0021-972X/97/$03.00/0 Vol. 82, No. 11 Journal of Clinical Endocrinology and Metabolism Copyright 1997 by The Endocrine Society

0021-972X/97/$03.00/0 Vol. 82, No. 11 Journal of Clinical Endocrinology and Metabolism Copyright 1997 by The Endocrine Society 0021-972X/97/$03.00/0 Vol. 82, No. 11 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1997 by The Endocrine Society Pathological Tumor-Node-Metastasis (ptnm) Staging for Papillary

More information

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium European Journal of Endocrinology (2006) 154 787 803 ISSN 0804-4643 CONSENSUS STATEMENT European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

More information

The Relationship Between Lymphocytic Infiltration in the Thyroid Gland and Tumor Recurrence in Papillary Thyroid Carcinoma

The Relationship Between Lymphocytic Infiltration in the Thyroid Gland and Tumor Recurrence in Papillary Thyroid Carcinoma Turkish Journal of Endocrinology and Metabolism, (1999) 3 : 113-117 ORIGINAL ARTICLE The Relationship Between Lymphocytic Infiltration in the Thyroid Gland and Tumor Recurrence in Papillary Thyroid Carcinoma

More information

Sonographic Findings in the Surgical Bed After Thyroidectomy

Sonographic Findings in the Surgical Bed After Thyroidectomy Article Sonographic Findings in the Surgical Bed After Thyroidectomy Comparison of Recurrent Tumors and Nonrecurrent Lesions Jung Hee Shin, MD, Boo-Kyung Han, MD, Eun Young Ko, MD, Seok Seon Kang, MD Objective.

More information

RESEARCH COMMUNICATION

RESEARCH COMMUNICATION DOI:http://dx.doi.org/10.7314/APJCP.2012.13.4.1267 BRAF Mutation is Predictive of Occult Contralateral Carcinoma in Papillary Thyroid Microcarcinoma Cases RESEARCH COMMUNICATION Preoperative BRAF Mutation

More information

Pediatric Thyroid Cancer: Treatment Controversies; I-131 Radiotherapy

Pediatric Thyroid Cancer: Treatment Controversies; I-131 Radiotherapy Pediatric Thyroid Cancer: Treatment Controversies; I-131 Radiotherapy Marguerite T. Parisi, M.D., M.S. Ed. Associate Professor, Departments of Radiology and Pediatrics University of Washington School of

More information

GENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE

GENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE Genomics in Medicine Series GENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE Electron Kebebew, MD, FACS Outline To assess the change in thyroid cancer epidemiology

More information

BRAF as a prognostic marker in papillary thyroid cancer

BRAF as a prognostic marker in papillary thyroid cancer 12 Congresso Nazionale AME Molecular markers in thyroid cancer: current role in clinical practice BRAF as a prognostic marker in papillary thyroid cancer Dott. ssa Cristina Romei Sezione di Endocrinologia

More information

Clinicopathological features of recurrent papillary thyroid cancer

Clinicopathological features of recurrent papillary thyroid cancer Zhu et al. Diagnostic Pathology (2015) 10:96 DOI 10.1186/s13000-015-0346-5 RESEARCH Open Access Clinicopathological features of recurrent papillary thyroid cancer Jian Zhu 1, Xinli Wang 2, Xiaoxuan Zhang

More information

Thyroid Cancer Basics

Thyroid Cancer Basics Thyroid Cancer Basics This handbook provides an overview of basic facts about thyroid cancer, its diagnosis, and typical treatment options. While this handbook contains important information about thyroid

More information

Medical Policy Manual. Topic: Molecular Markers in Fine Needle Aspirates of the Thyroid. Date of Origin: April 2013

Medical Policy Manual. Topic: Molecular Markers in Fine Needle Aspirates of the Thyroid. Date of Origin: April 2013 Medical Policy Manual Topic: Molecular Markers in Fine Needle Aspirates of the Thyroid Date of Origin: April 2013 Section: Genetic Testing Last Reviewed Date: December 2015 Policy No: 49 Effective Date:

More information

Molecular Markers in Fine Needle Aspirates of the Thyroid

Molecular Markers in Fine Needle Aspirates of the Thyroid Molecular Markers in Fine Needle Aspirates of the Thyroid Policy Number: 2.04.78 Last Review: 3/2015 Origination: 3/2013 Next Review: 3/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will

More information

Current management of papillary thyroid microcarcinoma in Canada

Current management of papillary thyroid microcarcinoma in Canada Merdad et al. Journal of Otolaryngology - Head and Neck Surgery 2014, 43:32 ORIGINAL RESEARCH ARTICLE Open Access Current management of papillary thyroid microcarcinoma in Canada Mazin Merdad 1,2, Antoine

More information

Thyroid Carcinoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 2.2014. NCCN.org. Continue

Thyroid Carcinoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 2.2014. NCCN.org. Continue NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 2.2014 NCCN.org Continue Version 2.2014, 08/12/2014 National Comprehensive Cancer Network, Inc. 2014, All rights reserved. The NCCN

More information

Kidney Cancer OVERVIEW

Kidney Cancer OVERVIEW Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney

More information

Classificazioni citologiche: verso uno schema internazionale unificato?

Classificazioni citologiche: verso uno schema internazionale unificato? Cytology and molecular biology for thyroid nodules diagnos6c categories to clinical ac6ons From Classificazioni citologiche: verso uno schema internazionale unificato? A. Crescenzi Diagnostic categories

More information

Probe: Could you tell me about when?

Probe: Could you tell me about when? PERIODIC ASSESSMENT OF TREATMENT AND VITAL/DISEASE STATUS Periodic Assessment of Cancer Treatment and Disease Status (To be administered to patient at 3 months and reviewed at 6, 9 and 12 months) Instructions:

More information

Pediatric Oncology for Otolaryngologists

Pediatric Oncology for Otolaryngologists Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department

More information

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History

More information

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Kerry C. Councilman, MD Assistant Professor University of Colorado Denver Goals: BRAF Mutation

More information

Application of Molecular Diagnosis: Present and Future

Application of Molecular Diagnosis: Present and Future Application of Molecular Diagnosis: Present and Future Dong Jun Lim, MD., PhD. Associate Professor Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary s Hospital,

More information

Thymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.

Thymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available. Thymus Cancer Introduction Thymus cancer is a rare cancer. It starts in the small organ that lies in the upper chest under the breastbone. The thymus makes white blood cells that protect the body against

More information

Guidelines for Management of Renal Cancer

Guidelines for Management of Renal Cancer Guidelines for Management of Renal Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Versions 2 and 3 Section 5 updated bullets 5.3 and 5.4 Section 6 updated

More information

Name of Policy: Molecular Markers in Fine Needle Aspirates of the Thyroid

Name of Policy: Molecular Markers in Fine Needle Aspirates of the Thyroid Name of Policy: Molecular Markers in Fine Needle Aspirates of the Thyroid Policy #: 516 Latest Review Date: June 2015 Category: Laboratory Policy Grade: B Background/Definitions: As a general rule, benefits

More information

Well-differentiated Thyroid Carcinoma: Factors Predicting Recurrence and Survival

Well-differentiated Thyroid Carcinoma: Factors Predicting Recurrence and Survival Singapore Med J 2002 Vol 43(9) : 457-462 O r i g i n a l A r t i c l e Well-differentiated Thyroid Carcinoma: Factors Predicting Recurrence and Survival L H Y Lim, K C Soo, Y K Chong, F Gao, G S Hong,

More information

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. GENERAL CODING When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. Exception: You must review and revise EOD coding for prostate

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): 4/1/2015 Most Recent Review Date (Revised): 11/24/2015 Effective Date: 2/1/2016 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS

More information

The 2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Cancer: An Author s Perspective

The 2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Cancer: An Author s Perspective The 2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Cancer: An Author s Perspective AACE 2015 Hot Topics in Thyroid Practice May 13, 2015 Bryan R. Haugen, MD University

More information

Intensity Modulated Radiation Therapy (IMRT) for Thyroid Cancer

Intensity Modulated Radiation Therapy (IMRT) for Thyroid Cancer Thyroid Science 5(1):CLS1-8, 2010 www.thyroidscience.com Clinical and Laboratory Studies Intensity Modulated Radiation Therapy (IMRT) for Thyroid Cancer 1 2 5 Aruna Turaka, MD, Tianyu Li, MS, Jian Q. Yu,

More information

Small Cell Lung Cancer

Small Cell Lung Cancer Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually

More information

Nicole Kounalakis, MD

Nicole Kounalakis, MD Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations

More information

The Di Bella Method (DBM) improves Survival, Objective Response and Performance Status in Breast Cancer

The Di Bella Method (DBM) improves Survival, Objective Response and Performance Status in Breast Cancer BIT's 4th World Cancer Congress 2011 People s Republic of China Dalian The Di Bella Method (DBM) improves Survival, Objective Response and Performance Status in treated with DBM therapy Retrospective observational

More information

Case Number: RT2009-124(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

Case Number: RT2009-124(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor Renal Cell Carcinoma of the Left Kidney Post Radical Surgery with pt4 Classification with Multiple Lung and Single Brain Metastases: the Role and Treatment Consideration of Radiotherapy Case Number: RT2009-124(M)

More information

How To Treat Lung Cancer At Cleveland Clinic

How To Treat Lung Cancer At Cleveland Clinic Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular

More information

Clinical Study BRAF Testing in Multifocal Papillary Thyroid Carcinoma

Clinical Study BRAF Testing in Multifocal Papillary Thyroid Carcinoma BioMed Research International Volume 2015, Article ID 486391, 7 pages http://dx.doi.org/10.1155/2015/486391 Clinical Study BRAF Testing in Multifocal Papillary Thyroid Carcinoma Hillary Z. Kimbrell, 1

More information

The American Joint Committee on Cancer (AJCC)

The American Joint Committee on Cancer (AJCC) THY-2012-0043-ver9-Randolph_3P.3d 10/13/12 6:42am Page 1 THYROID Volume 22, Number 11, 2012 ª Mary Ann Liebert, Inc. DOI: 10.1089/thy.2012.0043 THYROID CANCER AND NODULES The Prognostic Significance of

More information

D. FREQUENTLY ASKED QUESTIONS

D. FREQUENTLY ASKED QUESTIONS ACR BI-RADS ATLAS D. FREQUENTLY ASKED QUESTIONS 1. Under MQSA, is it necessary to include a numeric assessment code (i.e., 0, 1, 2, 3, 4, 5, or 6) in addition to the assessment category in all mammography

More information

Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method

Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method Christopher Martel, M.Sc., CHP Lisa Thornhill,, NRRPT, RT(NM) Boston University Medical Center Thyroid Carcinoma New cases and deaths in

More information

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200 GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung

More information

Chapter 2 Staging of Breast Cancer

Chapter 2 Staging of Breast Cancer Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination

More information

Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin

Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin E L Mazzaferri 1 and N Massoll 2 1 Adjunct Professor of Medicine, University of

More information

Surgical Staging of Endometrial Cancer

Surgical Staging of Endometrial Cancer Surgical Staging of Endometrial Cancer I. Endometrial Cancer Surgical Staging Overview Uterine cancer types: carcinomas type I and type II, sarcomas, carcinosarcomas Hysterectomy with BSO Surgical Staging

More information

Frozen Section Diagnosis

Frozen Section Diagnosis Frozen Section Diagnosis Dr Catherine M Corbishley Honorary Consultant Histopathologist St George s Healthcare NHS Trust and lead examiner final FRCPath Practical 2008-2011 Frozen Section Diagnosis The

More information

Staging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual

Staging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual Staging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual Jatin P. Shah, MD, PhD (Hon) Memorial Sloan-Kettering Cancer Center New York, New York The American

More information

Oxford Centre for Head and Neck Oncology The Thyroid Gland and Thyroid Cancer Information for patients

Oxford Centre for Head and Neck Oncology The Thyroid Gland and Thyroid Cancer Information for patients Oxford University Hospitals NHS Trust Oxford Centre for Head and Neck Oncology The Thyroid Gland and Thyroid Cancer Information for patients What is the thyroid gland? The thyroid gland is an endocrine

More information

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent

More information

Lung Cancer Treatment Guidelines

Lung Cancer Treatment Guidelines Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,

More information

A Practical Guide to Advances in Staging and Treatment of NSCLC

A Practical Guide to Advances in Staging and Treatment of NSCLC A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging

More information

Directly Coded Summary Stage Is Back

Directly Coded Summary Stage Is Back Directly Coded Summary Stage Is Back Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry June 30, 2015 1 Outline What is SEER Summary Stage 2000 (SS2000)? Summary Stage Housekeeping

More information

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA Papillary carcinoma is the most common of thyroid malignancies and occurs in all age groups but particularly in women under 45 years of age. There is a high rate of cervical metastatic disease and yet

More information

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the

More information

Predictive value of braf V600E mutational analysis in patients with differentiated thyroid cancer (DTC) submitted to radioiodine treatment (RAI)

Predictive value of braf V600E mutational analysis in patients with differentiated thyroid cancer (DTC) submitted to radioiodine treatment (RAI) Predictive value of braf V600E mutational analysis in patients with differentiated thyroid cancer (DTC) submitted to radioiodine treatment (RAI) D.A. Pizzuto1, S. Annunziata1, C. Brunelli2, G. Perotti1,

More information

Neoplasms of the LUNG and PLEURA

Neoplasms of the LUNG and PLEURA Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:

More information

Review Article To Treat or Not to Treat: The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients

Review Article To Treat or Not to Treat: The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients Hindawi Publishing Corporation Journal of Oncology Volume 2012, Article ID 707156, 11 pages doi:10.1155/2012/707156 Review Article To Treat or Not to Treat: The Role of Adjuvant Radioiodine Therapy in

More information

Salute to Dr. Saul Hertz Diagnostic and Therapeutic Uses of Radioiodine

Salute to Dr. Saul Hertz Diagnostic and Therapeutic Uses of Radioiodine Salute to Dr. Saul Hertz Diagnostic and Therapeutic Uses of Radioiodine Salute to Dr. Saul Hertz Diagnostic and Therapeutic Uses of Radioiodine Douglas Van Nostrand, MD, FACP, FACNM Director, Nuclear Medicine

More information

Papillary Thyroid Cancer with Chest Metastases Only Detected Using Radioactive Iodine

Papillary Thyroid Cancer with Chest Metastases Only Detected Using Radioactive Iodine Original Article 663 Papillary Thyroid Cancer with Chest Metastases Only Detected Using Radioactive Iodine Sheng-Fong Kuo, MD; Szu-Tah Chen, MD, PhD; Pan-Fu Kao 1, MD; Yu-Chen Chang 1, MD; Shuo-Chi Chou,

More information